Comparative Effectiveness Language Clarified In Compromise Stimulus Bill
This article was originally published in The Tan Sheet
Executive Summary
Congress took steps in its final version of the economic stimulus package to alleviate concerns that the comparative effectiveness research provisions will lead to the government making cost-based comparisons or making coverage and reimbursement decisions based on the research
You may also be interested in...
Comparative Effectiveness Bill Allows Industry Input Into Study Selection
A bill introduced in the House would prevent the government from being the sole director of comparative effectiveness research by setting up an independent institute overseen by a broad array of stakeholders, including industry
U.S. Comparative Effectiveness Will Not Copy U.K.’s NICE – OMB Director
The Obama administration is not looking to build a government entity charged with making cost-effectiveness decisions when reviewing the clinical effectiveness of medical treatments, according to Office of Management and Budget Director Peter Orszag
Baucus Maintains Public/Private Comparative Effectiveness Vision
Senate Finance Committee Chairman Max Baucus continues planning to include comparative effectiveness in the health care reform debate, even with research funding included in the American Recovery and Reinvestment Act